 , Acids, Acyclic , Anti-epileptic Agent , Anticonvulsants , Antimanic Agents , Antineoplastic Agents , Central Nervous System Agents , Central Nervous System Depressants , Cytochrome P-450 CYP1A2 Inhibitors , Cytochrome P-450 CYP1A2 Inhibitors (strength unknown) , Cytochrome P-450 CYP2A6 Substrates , Cytochrome P-450 CYP2A6 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 CYP2B6 Substrates , Cytochrome P-450 CYP2B6 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 CYP2C19 Inhibitors , Cytochrome P-450 CYP2C19 Inhibitors (weak) , Cytochrome P-450 CYP2C19 Substrates , Cytochrome P-450 CYP2C19 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 CYP2C8 Inhibitors , Cytochrome P-450 CYP2C9 Inhibitors , Cytochrome P-450 CYP2C9 Inhibitors (moderate) , Cytochrome P-450 CYP2C9 Substrates , Cytochrome P-450 CYP2C9 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 CYP3A Inhibitors , Cytochrome P-450 CYP3A Substrates , Cytochrome P-450 CYP3A4 Inhibitors , Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) , Cytochrome P-450 CYP3A5 Substrates , Cytochrome P-450 CYP3A5 Substrates with a Narrow Therapeutic Index , Cytochrome P-450 Enzyme Inhibitors , Cytochrome P-450 Substrates , Decreased Central Nervous System Disorganized Electrical Activity , Drugs causing inadvertant photosensitivity , Enzyme Inhibitors , Fatty Acid Derivatives , Fatty Acids , Fatty Acids, Volatile , GABA Agents , Hepatotoxic Agents , Highest Risk QTc-Prolonging Agents , Histone Deacetylase Inhibitors , Lipids , Methemoglobinemia Associated Agents , Miscellaneous Anticonvulsants , Mood Stabilizer , Narrow Therapeutic Index Drugs , Nervous System , Neurotransmitter Agents , OAT1/SLC22A6 inhibitors , OAT3/SLC22A8 Inhibitors , OAT3/SLC22A8 Substrates , OAT3/SLC22A8 Substrates with a Narrow Therapeutic Index , Organic Anion Transporting Polypeptide 2B1 Inhibitors , Pentanoic Acids , Photosensitizing Agents , Psychotropic Drugs , QTc Prolonging Agents , Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome , Tranquilizing Agents , UGT1A1 Inhibitors , UGT1A1 Substrates , UGT1A1 Substrates with a Narrow Therapeutic Index , UGT1A3 substrates , UGT1A3 Substrates with a Narrow Therapeutic Index , UGT1A4 substrates , UGT1A6 substrate , UGT1A6 Substrates with a Narrow Therapeutic Index , UGT1A9 Substrates , UGT1A9 Substrates with a Narrow Therapeutic Index , UGT2B7 substrates , UGT2B7 Substrates with a Narrow Therapeutic Index , Valerates